Overview

This book is a comprehensive, concise summary of the pharmacological treatments of prostate cancer. It is an authoritative and up-to-date reference on therapeutic options involving both standard of care and investigational agents. The chapters describe state of the art information on Hormone Therapy, Chemotherapy, Angiogenesis, Therapy for Bone Metastases, Immunotherapy, Prevention, and Drug Development. Drug Management of Prostate Cancer is an excellent resource for medical oncologists, trainees, researchers, and members of the pharmaceutical industry.

Full Product Details

9781282983069

Table of Contents

Reviews

From the reviews: For medical oncologists, trainees, researchers, and those in the pharmaceutical industry, Figg offer a comprehensive and concise summary of the pharmacological treatments for prostate cancer, both current standard and investigative options. The 36 chapters focus on a multidisciplinary care approach and cover hormone therapy, chemotherapy, angiogenesis, therapy for bones metastases, immunotherapy, chemoprevention, and drug development. Cell biology and molecular targets are also discussed. (SciTech Book News, December, 2010) The 36 chapters in this book read as independent discussions of many of the most recent discoveries in the area of drug management of prostate cancer. suitable for medical students, physicians in training, physicians (especially medical oncologists), scientists, translational researchers, and members of the pharmaceutical industry. An important aspect of this book is that the data represents updated, state-of-the-art information, making i

Author Information

Tab Content 6

Countries Available